Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
Recruiting · NCT06375239 · Registry updated 2025-01-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Stargardt disease, X-linked disease, choroideremia, eye disorder, hereditary disease, inherited retinal dystrophy, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, retinitis pigmentosa, uveal disorder | Recruiting | Not stated | 2025-01-08 | NCT06375239 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ray Therapeutics, Inc. | 4 |
| The Vision Research and Assessment Institute (VRAI) | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Vision Research and Assessment Institute | Irvine | United States | 1 |